Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,137 | 23,251 | 28,450 | 41,624 | 57,633 |
| Marketable Securities | 85,629 | 96,436 | 106,083 | 105,163 | 105,357 |
| Receivables | 16,570 | 17,455 | 10,366 | 11,153 | 7,333 |
| TOTAL | $124,597 | $140,230 | $147,970 | $160,602 | $171,851 |
| Non-Current Assets | |||||
| PPE Net | 9,025 | 8,991 | 8,701 | 8,393 | 7,307 |
| Investments And Advances | 19,830 | 25,296 | 27,026 | 27,449 | 19,993 |
| Intangibles | 18,142 | 18,550 | 18,963 | 13,810 | 14,019 |
| Other Non-Current Assets | 2,113 | 1,482 | 1,326 | 1,035 | 671 |
| TOTAL | $49,110 | $54,319 | $56,016 | $50,687 | $41,990 |
| Total Assets | $173,707 | $194,549 | $203,985 | $211,288 | $213,841 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,670 | 16,677 | 13,309 | 12,310 | 13,230 |
| Accrued Expenses | 6,368 | 7,216 | 5,006 | 4,151 | 2,601 |
| Other current liabilities | 1,168 | 1,813 | 1,815 | 1,707 | 1,301 |
| TOTAL | $43,823 | $41,375 | $35,495 | $33,399 | $31,466 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,617 | 15,668 | 15,364 | 15,231 | 14,335 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $6,506 | $6,197 | $6,401 | $6,672 | $6,441 |
| Total Liabilities | $50,329 | $47,571 | $41,896 | $40,071 | $37,908 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,173 | 6,169 | 6,127 | 6,089 | 6,016 |
| Common Shares | 74 | 74 | 74 | 72 | 72 |
| Retained earnings | -434,838 | -408,605 | -387,845 | -369,141 | -361,098 |
| Other shareholders' equity | 1,424 | 2,756 | 3,611 | 3,155 | 2,954 |
| TOTAL | $123,378 | $146,978 | $162,090 | $171,218 | $175,933 |
| Total Liabilities And Equity | $173,707 | $194,549 | $203,985 | $211,288 | $213,841 |